L-carnitine protects against nickel-induced neurotoxicity by maintaining mitochondrial function in Neuro-2a cells.

Min-Di He,Shang-Cheng Xu,Yong-Hui Lu,Li Li,Min Zhong,Yan-Wen Zhang,Yuan Wang,Min Li,Ju Yang,Guang-Bin Zhang,Zheng-Ping Yu,Zhou Zhou
DOI: https://doi.org/10.1016/j.taap.2011.03.008
IF: 4.46
2011-01-01
Toxicology and Applied Pharmacology
Abstract:Mitochondrial dysfunction is thought to be a part of the mechanism underlying nickel-induced neurotoxicity. L-carnitine (LC), a quaternary ammonium compound biosynthesized from the amino acids lysine and methionine in all mammalian species, manifests its neuroprotective effects by improving mitochondrial energetics and function. The purpose of this study was to investigate whether LC could efficiently protect against nickel-induced neurotoxicity. Here, we exposed a mouse neuroblastoma cell line (Neuro-2a) to different concentrations of nickel chloride (NiCl2) (0.25, 0.5, 1, and 2mM) for 24h, or to 0.5mM and 1mM NiCl2 for various periods (0, 3, 6, 12, or 24h). We found that nickel significantly increased the cell viability loss and lactate dehydrogenase (LDH) release in Neuro-2a cells. In addition, nickel exposure significantly elevated reactive oxygen species (ROS) and malondialdehyde (MDA) levels, disrupted the mitochondrial membrane potential (ΔΨm), reduced adenosine-5′-triphosphate (ATP) concentrations and decreased mitochondrial DNA (mtDNA) copy numbers and mtRNA transcript levels. However, all of the cytotoxicities and mitochondrial dysfunctions that were triggered by nickel were efficiently attenuated by pretreatment with LC. These protective effects of LC may be attributable to its role in maintaining mitochondrial function in nickel-treated cells. Our results suggest that LC may have great pharmacological potential in protecting against the adverse effects of nickel in the nervous system.
What problem does this paper attempt to address?